FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections (Q2906304): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
(Added qualifier: readability score (P590521): 0.000011549073841409742) |
||||||||||||||
(6 intermediate revisions by 2 users not shown) | |||||||||||||||
Property / start time | |||||||||||||||
| |||||||||||||||
Property / start time: 7 November 2016 / rank | |||||||||||||||
Property / end time | |||||||||||||||
| |||||||||||||||
Property / end time: 6 November 2017 / rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
Property / beneficiary name (string): INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: Q2993187 (Deleted Item) / rank | |||||||||||||||
Property / budget | |||||||||||||||
| |||||||||||||||
Property / budget: 6,463.0 Euro / rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
| |||||||||||||||
Property / EU contribution: 5,494.0 Euro / rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
| |||||||||||||||
Property / co-financing rate: 85.01 percent / rank | |||||||||||||||
Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549073841409742
| |||||||||||||||
Property / contained in Local Administrative Unit | |||||||||||||||
Property / contained in Local Administrative Unit: União das freguesias de Cedofeita, Santo Ildefonso, Sé, Miragaia, São Nicolau e Vitória / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / priority axis | |||||||||||||||
Property / priority axis: Strengthening research, technological development and innovation (OT1) / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / thematic objective | |||||||||||||||
Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / start time | |||||||||||||||
11 July 2016
| |||||||||||||||
Property / start time: 11 July 2016 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / end time | |||||||||||||||
11 June 2017
| |||||||||||||||
Property / end time: 11 June 2017 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / budget | |||||||||||||||
5,588.34 Euro
| |||||||||||||||
Property / budget: 5,588.34 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
4,750.09 Euro
| |||||||||||||||
Property / EU contribution: 4,750.09 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / co-financing rate | |||||||||||||||
85.0 percent
| |||||||||||||||
Property / co-financing rate: 85.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA | |||||||||||||||
Property / beneficiary name (string): INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank |
Latest revision as of 13:05, 20 March 2024
Project Q2906304 in Portugal
Language | Label | Description | Also known as |
---|---|---|---|
English | FAVHIV .: A composition for use in a method for prevention or treatment of human immunodefitiency virus infections |
Project Q2906304 in Portugal |
Statements
4,750.09 Euro
0 references
5,588.34 Euro
0 references
85.0 percent
0 references
11 July 2016
0 references
11 June 2017
0 references
INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
0 references
Porto
0 references
14 November 2023
0 references
Identifiers
POCI-01-0145-FEDER-026103
0 references